Document Detail


Intravenous magnesium sulphate in acute myocardial infarction--is the answer "MAGIC"?
MedLine Citation:
PMID:  12735485     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of magnesium in coronary artery disease has been evaluated extensively during the last three decades. The intravenous application of magnesium in acute myocardial infarction is of major importance, the beneficial effects have been underlined in several studies. Magnesium is of significance in the pathomechanisms of reperfusion injury and reduction of malign arrhythmias in the critical acute phase of myocardial infarction, if applied intravenously. However, the promising results of LIMIT-2 could not be confirmed by the data of ISIS-4. The timing of magnesium therapy is probably the most important key factor. Similar to the guidelines of thrombolytic intervention, magnesium has to be administered as early as possible, at the latest before myocardial reperfusion has started. Nevertheless, because of conflicting results of prior trials doubts on the efficacy of intravenous magnesium in myocardial infarction still remain. The multinational, multicenter trial MAGIC has been set up to evaluate the optimal patient cohort as well as the ideal dose regimen for the application of intravenous magnesium sulphate in patients with acute myocardial infarction. The answer on the open questions on intravenous magnesium sulphate in myocardial infarction could be "MAGIC".
Authors:
Ronald Smetana; H Georg Stühlinger; Katharina Kiss; Dietmar H Glogar
Related Documents :
8783025 - Environmental magnesium deficiency as a cardiovascular risk factor.
9298105 - Streptokinase, complement activation and hypotension.
2614925 - The effect of flosequinan in patients with acute-onset heart failure complicating acute...
2600615 - Streptokinase use in children undergoing cardiac catheterization.
10026365 - Ecg diagnosis of native heart ventricular tachycardia in a heterotopic heart transplant...
6720545 - Anterolateral st segment depression in acute inferior myocardial infarction: angiograph...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Magnesium research : official organ of the International Society for the Development of Research on Magnesium     Volume:  16     ISSN:  0953-1424     ISO Abbreviation:  Magnes Res     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-05-08     Completed Date:  2003-12-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8900948     Medline TA:  Magnes Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  65-9     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine IV, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Infusions, Intravenous
Magnesium Sulfate / administration & dosage,  therapeutic use*
Multicenter Studies as Topic / methods*,  statistics & numerical data
Myocardial Infarction / drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Marfan syndrome, magnesium status and medical prevention of cardiovascular complications by hemodyna...
Next Document:  Paradoxical drug response and the placebo effect: a discussion of Grunbaum's definitional scheme.